Unbiased AI-powered news
10 stories related to this topic, newest first.
A podcast host is preparing to record an interview with a practicing physician who studies peptides. The physician's compensation is unrelated to peptide promotion.
fda.govAn FDA advisory committee is scheduled to evaluate authorizing compounding pharmacies to produce certain injectable peptides in July 2026. This follows a March 2026 public meeting where peptide inclusion in oral dietary supplements was discussed. The moves come amid ongoing debat…
channelnewsasia.comPhysicians at longevity clinics have observed increased interest in injectable peptides for weight loss and anti-aging. They report cases of adverse effects including allergic reactions and hormone disturbances from unauthorized use. Discussions with seven doctors highlight conce…
medpagetoday.comThe U.S. Food and Drug Administration announced a panel meeting to discuss permitting compounding pharmacies to manufacture seven specific peptides. The meeting is scheduled for July 23 and 24. This follows the agency's 2023 decision to remove 19 peptides from an approved list fo…
Substrate placeholder — needs reviewHealth and Human Services Secretary Robert F. Kennedy Jr. is advocating for reduced restrictions on 14 synthetic peptides currently classified as Category 2 by the FDA. This move aims to allow licensed compounding pharmacies to produce them for patient use. Physicians have shared…
Substrate placeholder — needs reviewNeuroscientist Andrew Huberman stated that women form a significant part of the peptide market, particularly in sharing GLP and Retatrutide products. He mentioned that about 45% of his Huberman Lab Podcast listenership is female. Huberman receives frequent questions from female l…
Substrate placeholder — needs reviewAn independent laboratory tested samples of three peptides commonly used in wellness and performance enhancement. The tests found lead in BPC-157, endotoxins in TB-500, and less than 42% of the advertised dose in CJC-1295. These findings occur amid broader concerns over the lack…
Substrate placeholder — needs reviewLaboratories in the UK and internationally are processing thousands of samples of unregulated peptides sent by consumers for quality verification. These substances, often marketed for weight loss, biohacking, and anti-aging, include experimental compounds like retatrutide, which…
NIH Image Gallery from Bethesda, Maryland, USA / Wikimedia (Public domain)Health and wellness influencers are promoting unapproved peptide injections through gray market channels. These treatments lack FDA approval and pose risks to consumer health. The trend raises questions about the agency's regulatory future.
Substrate placeholder — needs reviewSynthetic peptides are increasingly used by individuals for enhancing strength, energy, recovery, and libido, often purchased from unregulated sources. These compounds lack FDA approval and human clinical data, raising risks of contamination and unknown effects. Investigations re…